Patients with systemic lupus erythematosus and secondary antiphospholipid syndrome have decreased numbers of circulating CD4+CD25+Foxp3+ Treg and CD3

Patients with systemic lupus erythematosus and secondary antiphospholipid syndrome have decreased numbers of circulating CD4+CD25+Foxp3+ Treg and CD3– CD19+ B cells

Published:2014-05 Issue:3 Volume:54 Page:241-246
ISSN:2255-5021
Container-title:Revista Brasileira de Reumatologia (English Edition)
language:en
Short-container-title:Revista Brasileira de Reumatologia (English Edition)

Author:

Ben Ester Rosári Raphaelli Dal,Prado Carine Hartmann do,Baptista Talita Siara Almeida,Bauer Moisés Evandro,Staub Henrique Luiz

Publisher

Elsevier BV

Reference26 articles.

1. Systemic lupus erythematosus – a contemporary view of its genetic determination, immunopathogenesis and therapy;Buc;Epidemiol Mikrobiol Imunol.,2009

2. Links between type I interferons and the genetic basis of disease in mouse lupus;Jorgensen;Autoimmunity.,2003

3. Thrombosis in systemic lupus erythematosus: risk and protection;Burgos;Expert Rev Cardiovasc Ther.,2009

4. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation;Tang;Nat Immunol.,2008

5. Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new;Alunno;Clin Dev Immunol.,2012

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential role of EBV and Toll-like receptor 9 ligand in patients with systemic lupus erythematosus;Immunologic Research;2023-04-25

2. Cell phenotypes as activity biomarkers in patients with Systemic Lupus Erythematosus;Brazilian Journal of Pharmaceutical Sciences;2023

3. Preliminary Study on the Imbalance Between Th17 and Regulatory T Cells in Antiphospholipid Syndrome;Frontiers in Immunology;2022-05-06

4. The Expression of P2X7 Receptor on Th1, Th17, and Regulatory T Cells in Patients with Systemic Lupus Erythematosus or Rheumatoid Arthritis and Its Correlations with Active Disease;The Journal of Immunology;2020-08-31

5. Androgen-Mediated Anti-inflammatory Cellular Processes as Therapeutic Targets in Lupus;Frontiers in Immunology;2020-06-23